-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2023-510382-10-00
5
2025-08-25
HELLP syndrome
-
2024-519331-42-00
5
2025-08-22
pMMR endometrial carcinoma
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2024-519667-18-00
6
2025-08-21
Pancreatic conditions requiring pancreaticoduodenectomy, such as pancr
-
2024-515561-34-01
6
2025-08-04
Acute ischemic stroke with recent ingestion of direct oral anticoagula
-
2024-514740-82-00
6
2025-07-16
Inflammatory Bowel Disease
-
2024-515884-69-00
5
2025-07-16
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
-
2024-512466-34-00
5
2025-07-10
High grade glioma (HGG)
-
2024-514066-40-00
4
2025-07-10
Patients with metastatic non-squamous NSCLC pre-treated with platinum-
-
2024-513683-25-00
4
2025-06-30
Patellofemoral osteoarthritis
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-518469-84-00
4
2025-06-20
Colorectal cancer
-
2024-512091-35-01
5
2025-06-17
Peripheral arterial disease
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2024-517457-27-00
5
2025-06-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-509391-42-00
11
2025-06-02
Chron's Disease
-
2023-506327-29-00
5
2025-05-14
Non-Small Cell Lung Cancer
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2024-519207-10-00
6
2025-05-12
Paroxysmal nocturnal hemoglobinuria (PNH)
-
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
-
2024-516152-17-00
4
2025-04-24
Cutaneous squamous cell carcinoma
-
2024-515279-37-00
5
2025-04-17
Relapsed or Refractory and Lenalidomide exposed Multiple Myeloma
-
2023-503424-12-00
6
2025-04-14
Type 2 diabetes